CB1 Capital Management predicts Cannabis could disrupt the healthcare industry in a big way. The firm's Founding Partner and Chief Investment Officer Todd Harrison explains why he thinks medical marijuana will migrate from state dispensaries, to become medicine prescribed by doctors through insurance in the next decade.
Harrison says the only way the U.S. government would get their hands on the money in this market opportunity is through the FDA. "That's where we think it goes, follow the money," says Harrison.
"This is not so much a trade about commerce, as it is a trade about healthcare," said Harrison. "We think that this is going to migrate towards medicine." One of CB1 Capital Management's holdings GW Pharmaceuticals is up 30 percent over the past three months. Harrison expects this company to publish research showing the efficacy of cannabis treatment this summer.
William Shatner and LifeWave CEO David Schmidt share lessons from his “world’s oldest intern” experience and offer advice for young professionals starting out.
The Live Nation ruling is in. Diana Moss of the Progressive Policy Institute joins us to unpack what it means for competition, consumers, and live music.
Madison Air CEO Jill Wyant on taking a century-old HVAC giant public and what the IPO means for the industry, investors, and the future of the company.
